Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease

Digestive and Liver Disease

Volumn 44, Issue 4, 2012, Pages 323-327

  Vieira, Jakeliny ^a   Oliveira, Pedro Vitoriano ^a   Juliano, Yara ^a   Warde, Karim Repsold Jorge ^a   Deguti, Marta Mitiko ^a   Barbosa, Egberto Reis ^a   Carrilho, Flair Jose ^a   Cancado, Eduardo Luiz Rachid ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

ATP7B heterozygotes; Cupriuresis; Hepatolenticular degeneration

Indexed keywords

CERULOPLASMIN; COPPER; PENICILLAMINE;

ADULT; ARTICLE; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG EXCRETION; FATHER; FEMALE; HETEROZYGOTE; HUMAN; MALE; MOTHER; PARENT; PRIORITY JOURNAL; SEX DIFFERENCE; URINARY COPPER EXCRETION; URINARY EXCRETION; WILSON DISEASE;

CERULOPLASMIN; CHELATING AGENTS; COPPER; FEMALE; HEPATOLENTICULAR DEGENERATION; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; PENICILLAMINE; SEX FACTORS;

EID: 84857645214     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.11.001     Document Type: Article

References (25)

1. Scheinberg I.H., Sternlieb I. Wilson disease and idiopathic copper toxicosis. Am J Clin Nutr 1996, 63:842S-845S.
2. Steindl P., Ferenci P., Dienes H.P., et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology 1997, 113:212-218.
3. Demirkiran M., Jankovic J., Lewis R.A., et al. Neurologic presentation of Wilson disease without Kayser-Fleischer rings. Neurology 1996, 46:1040-1043.
4. Roberts E.A., Schilsky M.L. Diagnosis and treatment of Wilson disease: an update. Hepatology 2008, 47:2089-2111.
5. Ala A., Walker A.P., Ashkan K., et al. Wilson's disease. Lancet 2007, 369:397-408.
6. Gollan J.L., Gollan T.J. Wilson disease in 1998: genetic, diagnostic and therapeutic aspects. J Hepatol 1998, 28(Suppl. 1):28-36.
7. Cauza E., Maier-Dobersberger T., Polli C., et al. Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin. J Hepatol 1997, 27:358-362.
8. Mak C.M., Lam C.W. Diagnosis of Wilson's disease: a comprehensive review. Crit Rev Clin Lab Sci 2008, 45:263-290.
9. Gow P.J., Smallwood R.A., Angus P.W., et al. Diagnosis of Wilson's disease: an experience over three decades. Gut 2000, 46:415-419.
10. LaRusso N.F., Summerskill W.H., McCall J.T. Abnormalities of chemical tests for copper metabolism in chronic active liver disease: differentiation from Wilson's disease. Gastroenterology 1976, 70(5 PT.1):653-655.
11. Tu J.B., Blackwell R.Q. Studies on levels of penicillamine-induced cupriuresis in heterozygotes of Wilson's disease. Metabolism 1967, 16:507-513.
12. Frommer D.J. Urinary copper excretion and hepatic copper concentrations in liver disease. Digestion 1981, 21:169-178.
13. Martins da Costa C., Baldwin D., Portmann B., et al. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. Hepatology 1992, 15:609-615.
14. Nicastro E., Ranucci G., Vajro P., et al. Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease. Hepatology 2010, 52:1948-1956.
15. Dhawan A., Taylor R.M., Cheeseman P., et al. Wilson's disease in children: 37-year experience and revised King's score for liver transplantation. Liver Transpl 2005, 11:441-448.
16. Ferenci P., Caca K., Loudianos G., et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003, 23:139-142.
17. Deguti M.M., Genschel J., Cancado E.L., et al. Wilson disease: novel mutations in the ATP7B gene and clinical correlation in Brazilian patients. Hum Mutat 2004, 23:398.
18. Muller T., Koppikar S., Taylor R.M., et al. Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children. J Hepatol 2007, 47:270-276.
19. Foruny J.R., Boixeda D., Lopez-Sanroman A., et al. Usefulness of penicillamine-stimulated urinary copper excretion in the diagnosis of adult Wilson's disease. Scand J Gastroenterol 2008, 43:597-603.
20. Oliveira P.V., Oliveira E. Multielement electrothermal atomic absorption spectrometry: a study on direct and simultaneous determination of chromium and manganese in urine. Fresenius J Anal Chem 2001, 371:909-914.
21. Mendez M.A., Araya M., Olivares M., et al. Sex and ceruloplasmin modulate the response to copper exposure in healthy individuals. Environ Health Perspect 2004, 112:1654-1657.
22. Leu M.L., Strickland G.T. Renal function in heterozygotes for Wilson's disease. Am J Med Sci 1972, 263:19-26.
23. McCall J.T., Goldstein N.P., Randall R.V., et al. Comparative metabolism of copper and zinc in patients with Wilson's disease (hepatolenticular degeneration). Am J Med Sci 1967, 254:13-23.
24. Eden A., Green H.H. Micro-determination of copper in biological material. Biochem J 1940, 34:1202-1208.
25. Spector H., Glusman S., Jatlow P., et al. Direct determination of copper in urine by atomic absorption spectrophotometry. Clin Chim Acta 1971, 31:5-11.